Skip to content

Clinical Efficacy of Novel Jasminum-based Calcium Hydroxide Medicament

Clinical Efficacy of Novel Jasminum-based Nano-reinforced Calcium Hydroxide Medicament on Postoperative Pain: a Triple-blind Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06653608
Enrollment
60
Registered
2024-10-22
Start date
2024-04-24
Completion date
2024-09-25
Last updated
2024-10-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Apical Periodontitis of Pulpal Origin, Necrotic Pulp

Keywords

Endodontic, Necrotic pulp, Apical Periodontitis

Brief summary

A triple-blind, parallel group, randomized trial with an allocation ratio of 1:1. Participants randomly allocated into two groups A and B. In group A, nano-reinforced calcium hydroxide medicament was utilized while in group B, calcium hydroxide medicament without nanoparticles was used. Post-operative pain was assessed after 4 hours, 24 hours, 48 hours, 72 hours, 96 hours.

Detailed description

This triple-blind parallel group, randomized clinical trial was conducted at the department of Operative Dentistry and Endodontics, School of Dentistry from April 24, 2024 to September 25, 2024. Participants were randomly distributed into two groups by Lottery method. A consecutive non-probability sampling technique was used. Before initiating treatment, participants were briefed about the intervention and their preoperative pain score was recorded. In both groups, endodontic treatment was initiated under rubber dam isolation. Access opening done and canals explored. Working length taken by radiographic method and reconfirmed by an electronic apex locator. Afterwards, canals were prepared till Master Apical File size F2 (4% Taper). In group A, Nano-reinforced calcium hydroxide medicament was placed while in group B, calcium hydroxide without nanoparticles was utilized. Participants were instructed to rate their postoperative pain record after 4hrs, 24hrs, 48hrs, 72hrs and 96hrs.

Interventions

DRUGNano-reinforced calcium hydroxide medicament

Group A (Calcium hydroxide intracanal medicament reinforced with jasminum derived- titania nanoparticles)

DRUGCalcium hydroxide without nanoparicles

Group B ( Calcium hydroxide medicament without nanoparticles)

Sponsors

Pakistan Institute of Medical Sciences
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Masking description

In this triple-blind trial, participants, care provider and outcome assessor were unaware of the study groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants with good general health status * Necrotic pulp with Symptomatic Apical Periodontitis * Single rooted teeth

Exclusion criteria

* Non-restorable teeth * Teeth associated with acute or chronic apical abscess * Teeth with chronic periodontitis * Teeth with anatomical complexities or complications like open apex, calcified canal, severe root dilaceration, root resorptive defects * Participants who received antibiotic treatment during the last 3 months * Pregnant females * Participants on pre-treatment analgesics

Design outcomes

Primary

MeasureTime frameDescription
Post-operative painOne weekPain scores assessed by Visual Analogue Scale (VAS) score after 4hr, 24hrs, 48hrs, 72hrs, 96hrs. The minimum score is O (None) and the maximum score is 10 (Severe).

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026